跳至主要内容
临床试验/NCT04073394
NCT04073394已完成不适用

"Mayo Clinic Diet" Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes (PHENO-Diet Trial)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 215 人开始时间: 2020年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
215
试验地点
2
主要终点
12-week total body weight loss

研究概览

简要总结

The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, and weight loss maintenance.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with obesity (BMI >30Kg/m2); these will be otherwise healthy individuals with no unstable psychiatric disease and uncontrolled life-threatening comorbidities (i.e. unstable angina).
  • Age: 18-65 years.
  • Gender: Men or women.

排除标准

  • Weight change greater than 3% in the previous 3 months (weight stable).
  • History of bariatric surgery including lap band and bariatric endoscopy.
  • Significant untreated psychiatric dysfunction including binge eating disorders and bulimia.
  • Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM
  • A positive score on the AUDIT-C questionnaire as judged by an investigator.
  • Patient has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder study adherence

结局指标

主要结局

12-week total body weight loss

时间窗: 12 weeks

Change in body weight during the 12 week study

次要结局

  • Waist Circumference(12 weeks)
  • Gastric Emptying 2 Hours(12 weeks)
  • Gastric Emptying(12 weeks)
  • Adherence(12 weeks)
  • Calorie Intake(12 weeks)
  • Anxiety Level(12 weeks)
  • Emotional Eating(12 weeks)
  • Responder Rate(12 weeks)
  • Fat Loss(12 weeks)
  • Calories to Fullness(12 weeks)
  • Resting Metabolic Rate(12 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andres J. Acosta, M.D., Ph.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验